{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:05:54Z","timestamp":1792001154743,"version":"4.4.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.intimp.2024.112793","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T20:43:00Z","timestamp":1723581780000},"page":"112793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Challenges and opportunities in research on BK virus infection after renal transplantation"],"prefix":"10.1016","volume":"141","author":[{"given":"Yukun","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunfeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2024.112793_b0005","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.kint.2020.09.003","article-title":"Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report","volume":"98","author":"Yang","year":"2020","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.intimp.2024.112793_b0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.semnephrol.2016.08.001","article-title":"Developing treatments for chronic kidney disease in the 21st century","volume":"36","author":"Breyer","year":"2016","journal-title":"Semin. Nephrol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.eururo.2017.09.021","article-title":"The gift of life: new opportunities from renal transplantation","volume":"73","author":"Sood","year":"2018","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/practneurol-2017-001657","article-title":"Neurological complications of renal dialysis and transplantation","volume":"18","author":"Karunaratne","year":"2018","journal-title":"Pract. Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.15971020","article-title":"Long-term infectious complications of kidney transplantation","volume":"17","author":"Agrawal","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112793_b0030","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/v14081616","article-title":"BK virus nephropathy in kidney transplantation: a state-of-the-art review","volume":"14","author":"Kant","year":"2022","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.intimp.2024.112793_b0035","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3390\/v13081502","article-title":"BK polyomavirus-biology, genomic variation and diagnosis","volume":"13","author":"Furmaga","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2024.112793_b0040","doi-asserted-by":"crossref","unstructured":"A.S. Saribas, P. Coric, A. Hamazaspyan, W. Davis, R. Axman, M.K. White, M. Abou-Gharbia, W. Childers, J.H. Condra, S. Bouaziz, M. Safak, Emerging from the unknown: structural and functional features of agnoprotein of polyomaviruses, J. Cell Physiol. 2016 Oct;231(10):2115-27. doi: 10.1002\/jcp.25329. Epub 2016 Feb 24. Erratum in: J Cell Physiol. 2016 Dec;231(12):2789. doi: 10.1002\/jcp.25465.","DOI":"10.1002\/jcp.25329"},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0045","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1084\/jem.20072097","article-title":"Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology","volume":"205","author":"Gosert","year":"2008","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.intimp.2024.112793_b0050","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/jmv.21605","article-title":"Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients","volume":"81","author":"Olsen","year":"2009","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/CMR.00074-16","article-title":"BK polyomavirus: clinical aspects, immune regulation, and emerging therapies","volume":"30","author":"Ambalathingal","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0060","doi-asserted-by":"crossref","first-page":"e2102","DOI":"10.1002\/rmv.2102","article-title":"BK polyomavirus diversity-Why viral variation matters","volume":"30","author":"Blackard","year":"2020","journal-title":"Rev. Med. Virol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/rmv.613","article-title":"Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications","volume":"19","author":"Yogo","year":"2009","journal-title":"Rev. Med. Virol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/v14020209","article-title":"Molecular epidemiology and Variation of the BK polyomavirus in the population of central and eastern Europe based on the example of Poland","volume":"14","author":"Furmaga","year":"2022","journal-title":"Viruses"},{"issue":"Pt 1","key":"10.1016\/j.intimp.2024.112793_b0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1099\/vir.0.83611-0","article-title":"Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race","volume":"90","author":"Zhong","year":"2009","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112793_b0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcv.2013.08.035","article-title":"JC and BK polyomavirus-specific immunoglobulin G responses in patients thymectomized in early childhood","volume":"58","author":"Prelog","year":"2013","journal-title":"J. Clin. Virol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112793_b0085","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/pbc.25536","article-title":"Antibodies to BK virus in children prior to allogeneic hematopoietic cell transplant","volume":"62","author":"Laskin","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.intimp.2024.112793_b0090","doi-asserted-by":"crossref","unstructured":"H.H. Hirsch, P.S. Randhawa, AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 33(9) (2019) e13528. doi: 10.1111\/ctr.13528.","DOI":"10.1111\/ctr.13528"},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0095","doi-asserted-by":"crossref","first-page":"e2044","DOI":"10.1002\/rmv.2044","article-title":"BK virus: current understanding of pathogenicity and clinical disease in transplantation","volume":"29","author":"Chong","year":"2019","journal-title":"Rev. Med. Virol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0100","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.transproceed.2018.12.016","article-title":"Renal function impairment in kidney transplantation: importance of early BK Virus detection","volume":"51","author":"Manzano S\u00e1nchez","year":"2019","journal-title":"Transpl. Proc."},{"issue":"1","key":"10.1016\/j.intimp.2024.112793_b0105","doi-asserted-by":"crossref","first-page":"e1007505","DOI":"10.1371\/journal.ppat.1007505","article-title":"Human polyomavirus BKV infection of endothelial cells results in interferon pathway induction and persistence","volume":"15","author":"An","year":"2019","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.intimp.2024.112793_b0110","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/v12080824","article-title":"Persistent BK polyomavirus viruria is associated with accumulation of VP1 mutations and neutralization escape","volume":"12","author":"McIlroy","year":"2020","journal-title":"Viruses"},{"issue":"20","key":"10.1016\/j.intimp.2024.112793_b0115","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1073\/pnas.1301907110","article-title":"miRNA regulation of BK polyomavirus replication during early infection","volume":"110","author":"Broekema","year":"2013","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.intimp.2024.112793_b0120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/ndt\/gfz214","article-title":"Risk factors, pathogenesis, presentation and management of BK virus infection in kidney transplantation","volume":"36","author":"Demir","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2024.112793_b0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcv.2017.09.004","article-title":"BK virus replication in renal transplant recipients: analysis of potential risk factors may contribute in reactivation","volume":"96","author":"Shenagari","year":"2017","journal-title":"J. Clin. Virol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112793_b0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/QCO.0000000000000602","article-title":"BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update","volume":"32","author":"Kaur","year":"2019","journal-title":"Curr Opin Infect Dis."},{"issue":"10","key":"10.1016\/j.intimp.2024.112793_b0135","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3389\/fimmu.2019.00767","article-title":"BKV clearance time correlates with exhaustion state and T-cell receptor repertoire shape of BKV-specific T-cells in renal transplant patients","volume":"10","author":"Stervbo","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112793_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005903","article-title":"Clinically relevant reactivation of polyomavirus BK (BKPyV) in HLA-A02-positive renal transplant recipients is associated with impaired effector-memory differentiation of BKPyV-specific CD8+ T Cells","volume":"12","author":"van Aalderen","year":"2016","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009042","article-title":"Non-permissive human conventional CD1c+ dendritic cells enable trans-infection of human primary renal tubular epithelial cells and protect BK polyomavirus from neutralization","volume":"17","author":"Sikorski","year":"2021","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0150","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcv.2013.11.009","article-title":"Donor origin of BKV replication after kidney transplantation","volume":"59","author":"Schmitt","year":"2014","journal-title":"J. Clin. Virol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0155","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12917","article-title":"Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation","volume":"20","author":"Grellier","year":"2018","journal-title":"Transpl. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/tid.12051","article-title":"Ureteral stent placement and BK viremia in kidney transplant recipients","volume":"15","author":"Kayler","year":"2013","journal-title":"Transpl. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.112793_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12644","article-title":"Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation","volume":"19","author":"Wingate","year":"2017","journal-title":"Transpl. Infect. Dis."},{"issue":"8","key":"10.1016\/j.intimp.2024.112793_b0170","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2215\/CJN.00770112","article-title":"Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients","volume":"7","author":"Sharif","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112793_b0175","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/TP.0b013e3182921995","article-title":"Risk factors for BK virus infection in the era of therapeutic drug monitoring","volume":"95","author":"Borni-Duval","year":"2013","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1016\/j.intimp.2024.112793_b0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajt.12110","article-title":"AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.intimp.2024.112793_b0185","article-title":"A nomogram for predicting BK virus activation in kidney transplantation recipients using clinical risk factors","volume":"10","author":"Wang","year":"2022","journal-title":"Front Med (lausanne)."},{"issue":"27","key":"10.1016\/j.intimp.2024.112793_b0190","article-title":"Risk factors for developing BK virus-associated nephropathy: a single-center retrospective cohort study of kidney transplant recipients","volume":"12","author":"Lorant","year":"2022","journal-title":"Ann. Transplant."},{"issue":"3","key":"10.1016\/j.intimp.2024.112793_b0195","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/TP.0000000000002376","article-title":"Reduced risk of BK polyomavirus infection in HLA-B51-positive kidney transplant recipients","volume":"103","author":"Wunderink","year":"2019","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.intimp.2024.112793_b0200","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/genes13071290","article-title":"BK virus infection and BK-virus-associated nephropathy in renal transplant recipients","volume":"13","author":"Borriello","year":"2022","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0205","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ndt\/gfz273","article-title":"BK polyomavirus-pathogen, paradigm and puzzle","volume":"36","author":"Kotla","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"issue":"12","key":"10.1016\/j.intimp.2024.112793_b0210","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1128\/JCM.01230-11","article-title":"Impact of genomic sequence variability on quantitative PCR assays for diagnosis of polyomavirus BK infection","volume":"49","author":"Randhawa","year":"2011","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112793_b0215","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/JCM.00258-08","article-title":"Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays","volume":"46","author":"Hoffman","year":"2008","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112793_b0220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4132\/KoreanJPathol.2012.46.3.233","article-title":"Urinary decoy cell grading and its clinical implications","volume":"46","author":"Koh","year":"2012","journal-title":"Korean J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0225","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1681\/ASN.2008010117","article-title":"Presence of urinary Haufen accurately predicts polyomavirus nephropathy","volume":"20","author":"Singh","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112793_b0230","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/TP.0000000000000367","article-title":"Polyomavirus nephropathy: quantitative urinary polyomavirus-Haufen testing accurately predicts the degree of intrarenal viral disease","volume":"99","author":"Singh","year":"2015","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.intimp.2024.112793_b0235","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2215\/CJN.13611119","article-title":"The importance of kidney medullary tissue for the accurate diagnosis of BK virus allograft nephropathy","volume":"15","author":"Nankivell","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112793_b0240","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1046\/j.1600-6143.2004.00603.x","article-title":"Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load","volume":"4","author":"Drachenberg","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2024.112793_b0245","doi-asserted-by":"crossref","unstructured":"V. Nickeleit, H.K. Singh, P. Randhawa, C.B. Drachenberg, R. Bhatnagar, E. Bracamonte, A. Chang, W.J. Chon, D. Dadhania, V.G. Davis, H. Hopfer, M.J. Mihatsch, J.C. Papadimitriou, S. Schaub, M.B. Stokes, M.F. Tungekar, S.V. Seshan, Banff Working Group on Polyomavirus Nephropathy. The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations, J. Am. Soc. Nephrol. 29(2) (2018) 680-693. doi: 10.1681\/ASN.2017050477.","DOI":"10.1681\/ASN.2017050477"},{"issue":"10","key":"10.1016\/j.intimp.2024.112793_b0250","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","article-title":"Polyomavirus BK","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"10.1016\/j.intimp.2024.112793_b0255","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/cid\/ciac071","article-title":"Consensus definitions of BK polyomavirus nephropathy in renal transplant recipients for clinical trials","volume":"75","author":"Imlay","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 7","key":"10.1016\/j.intimp.2024.112793_b0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1469-0691.12538","article-title":"ESCMID Study Group of Infection in Compromised Hosts. European perspective on human polyomavirus infection, replication and disease in solid organ transplantation","volume":"20","author":"Hirsch","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"issue":"11","key":"10.1016\/j.intimp.2024.112793_b0265","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1097\/TXD.0000000000001061","article-title":"Donor-derived Cell-free DNA and the Prediction of BK Virus-associated Nephropathy","volume":"6","author":"Kant","year":"2020","journal-title":"Transplant. Direct"},{"issue":"5","key":"10.1016\/j.intimp.2024.112793_b0270","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/medicina57050482","article-title":"Donor-derived cell-free DNA in kidney transplantation: origins, present and a look to the future","volume":"57","author":"Kant","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"35","key":"10.1016\/j.intimp.2024.112793_b0275","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.3389\/ti.2022.10448","article-title":"Donor derived cell free DNA in kidney transplantation: the Circa 2020\u20132021 Update","volume":"1","author":"Kant","year":"2022","journal-title":"Transpl. Int."},{"issue":"10","key":"10.1016\/j.intimp.2024.112793_b0280","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/infdis\/jiac440","article-title":"Urine Exosomal bkv-miR-B1-5p and BK virus nephropathy in kidney transplant recipients","volume":"227","author":"Jung","year":"2023","journal-title":"J. Infect. Dis."},{"issue":"13","key":"10.1016\/j.intimp.2024.112793_b0285","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.3390\/ijms23137240","article-title":"BK polyomavirus bkv-miR-B1-5p: A stable Micro-RNA to monitor active viral replication after kidney transplantation","volume":"23","author":"Demey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2024.112793_b0290","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1021\/acs.jproteome.2c00219","article-title":"S100A8\/A9, an Upregulated Host Factor in BK Virus Infection after Kidney Transplantation, Is Associated with Allograft Function Impairment","volume":"21","author":"Wang","year":"2022","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112793_b0295","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40620-016-0327-0","article-title":"Ultrasound findings of BK polyomavirus-associated nephropathy in renal transplant patients","volume":"30","author":"Dugo","year":"2017","journal-title":"J. Nephrol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0300","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiol.211855","article-title":"High-frequency US for BK polyomavirus-associated nephropathy after kidney transplant","volume":"304","author":"Yang","year":"2022","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.intimp.2024.112793_b0305","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy","volume":"10","author":"Schaub","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.intimp.2024.112793_b0310","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ndt\/gfy346","article-title":"Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes","volume":"34","author":"Bischof","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0315","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","article-title":"BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results","volume":"10","author":"Hardinger","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.intimp.2024.112793_b0320","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/tid.12313","article-title":"Observations on the use of cidofovir for BK virus infection in renal transplantation","volume":"16","author":"Kuten","year":"2014","journal-title":"Transpl. Infect. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2024.112793_b0325","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ndt\/gfn675","article-title":"The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients","volume":"24","author":"Wu","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.intimp.2024.112793_b0330","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.2215\/CJN.08261109","article-title":"Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation","volume":"5","author":"Gabardi","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112793_b0335","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/ajt.12218","article-title":"Pathology of resolving polyomavirus-associated nephropathy","volume":"13","author":"Menter","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2024.112793_b0340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nep.12462","article-title":"Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy","volume":"20","author":"Masutani","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0345","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1600-6143.2012.03993.x","article-title":"The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome","volume":"12","author":"Masutani","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2024.112793_b0350","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.diagmicrobio.2014.09.024","article-title":"Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis","volume":"81","author":"Huang","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"8","key":"10.1016\/j.intimp.2024.112793_b0355","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/TP.0b013e31826690c6","article-title":"Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study","volume":"94","author":"Sood","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2024.112793_b0360","doi-asserted-by":"crossref","unstructured":"M. Haas, A. Loupy, C. Lefaucheur, C. Roufosse, D. Glotz, D. Seron, B.J. Nankivell, P.F. Halloran, R.B. Colvin, E. Akalin, N. Alachkar, S. Bagnasco, Y. Bouatou, J.U. Becker, L.D. Cornell, J.P. Duong van Huyen, I.W. Gibson, E.S. Kraus, R.B. Mannon, M. Naesens, V. Nickeleit, P. Nickerson, D.L. Segev, H.K. Singh, M. Stegall, P. Randhawa, L. Racusen, K. Solez, M. Mengel, The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111\/ajt.14625.","DOI":"10.1111\/ajt.14625"},{"issue":"11","key":"10.1016\/j.intimp.2024.112793_b0365","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/TP.0000000000002366","article-title":"A 2018 reference guide to the banff classification of renal allograft pathology","volume":"102","author":"Roufosse","year":"2018","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0370","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13216","article-title":"Which is more nephrotoxic for kidney transplants: BK nephropathy or rejection?","volume":"32","author":"Parajuli","year":"2018","journal-title":"Clin. Transplant."},{"issue":"3","key":"10.1016\/j.intimp.2024.112793_b0375","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13194","article-title":"De novo donor-specific antibody following BK nephropathy: The incidence and association with antibody-mediated rejection","volume":"32","author":"Cheungpasitporn","year":"2018","journal-title":"Clin. Transplant."},{"issue":"8","key":"10.1016\/j.intimp.2024.112793_b0380","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/ajt.14292","article-title":"BK virus nephropathy: histological evolution by sequential pathology","volume":"17","author":"Nankivell","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.intimp.2024.112793_b0385","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/TP.0b013e3181837802","article-title":"Antirejection treatment in kidney transplant patients with BK viruria","volume":"86","author":"Kayler","year":"2008","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.intimp.2024.112793_b0390","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5507\/bp.2018.018","article-title":"BK virus-induced renal allograft nephropathy","volume":"162","author":"Krejci","year":"2018","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0395","doi-asserted-by":"crossref","first-page":"e13508","DOI":"10.1111\/tid.13508","article-title":"A pilot study of immunosuppression resumption following BK viremia resolution","volume":"23","author":"Alquadan","year":"2021","journal-title":"Transpl. Infect. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2024.112793_b0400","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1600-6143.2010.03083.x","article-title":"Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis","volume":"10","author":"Dharnidharka","year":"2010","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.intimp.2024.112793_b0405","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/ajt.15723","article-title":"Outcomes of kidney retransplantation after graft loss as a result of BK virus nephropathy in the era of newer immunosuppressant agents","volume":"20","author":"Leeaphorn","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.intimp.2024.112793_b0410","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/TP.0b013e31822d08c1","article-title":"Results of repeat renal transplantation after graft loss from BK virus nephropathy","volume":"92","author":"Geetha","year":"2011","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.intimp.2024.112793_b0415","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/ajt.16233","article-title":"Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients-Results from a proof-of-concept study","volume":"21","author":"Benotmane","year":"2021","journal-title":"Am. J. Transplant."},{"issue":"24","key":"10.1016\/j.intimp.2024.112793_b0420","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1200\/JCO.20.02608","article-title":"Third-party BK virus-specific cytotoxic T lymphocyte therapy for hemorrhagic cystitis following allotransplantation","volume":"39","author":"Olson","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112793_b0425","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01094-21","article-title":"Intracellular low iron exerts anti-BK polyomavirus effect by inhibiting the protein synthesis of exogenous genes","volume":"9","author":"Sun","year":"2021","journal-title":"Microbiol Spectr."},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0430","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s15010-022-01962-0","article-title":"Tumor necrosis factor-alpha blockade suppresses BK polyomavirus replication","volume":"51","author":"Li","year":"2023","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.intimp.2024.112793_b0435","article-title":"A polyomavirus peptide binds to the capsid VP1 pore and has potent antiviral activity against BK and JC polyomaviruses","volume":"21","author":"Kane","year":"2020","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.intimp.2024.112793_b0440","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.transproceed.2020.01.158","article-title":"Clinical characteristic and outcomes of BK virus infection in kidney transplant recipients managed using a systematic surveillance and treatment Strategy","volume":"52","author":"Lee","year":"2020","journal-title":"Transpl. Proc."},{"issue":"5","key":"10.1016\/j.intimp.2024.112793_b0445","doi-asserted-by":"crossref","first-page":"e13460","DOI":"10.1111\/petr.13460","article-title":"BK viremia and nephropathy in pediatric renal transplant recipients","volume":"23","author":"Hamasaki","year":"2019","journal-title":"Pediatr. Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2024.112793_b0450","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.transproceed.2014.11.008","article-title":"Everolimus-based immunosuppression therapy for BK virus nephropathy","volume":"47","author":"Polanco","year":"2015","journal-title":"Transpl. Proc."},{"issue":"8","key":"10.1016\/j.intimp.2024.112793_b0455","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.transproceed.2017.06.030","article-title":"Mycophenolate Mofetil withdrawal with conversion to everolimus to treat BK Virus infection in kidney transplant recipients","volume":"49","author":"Wojciechowski","year":"2017","journal-title":"Transpl. Proc."},{"issue":"3","key":"10.1016\/j.intimp.2024.112793_b0460","doi-asserted-by":"crossref","first-page":"E230","DOI":"10.1111\/ctr.12110","article-title":"Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy","volume":"27","author":"Cuellar-Rodriguez","year":"2013","journal-title":"Clin. Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2024.112793_b0465","doi-asserted-by":"crossref","first-page":"34","DOI":"10.15171\/jnp.2016.06","article-title":"Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy; a single center experience","volume":"5","author":"Nesselhauf","year":"2016","journal-title":"J Nephropathol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0470","doi-asserted-by":"crossref","first-page":"e13058","DOI":"10.1111\/tid.13058","article-title":"Clinical utility of leflunomide for BK polyomavirus associated nephropathy in kidney transplant recipients: A multicenter retrospective study","volume":"21","author":"Keller","year":"2019","journal-title":"Transpl. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2024.112793_b0475","doi-asserted-by":"crossref","first-page":"e13228","DOI":"10.1111\/tid.13228","article-title":"Low-dose cidofovir and conversion to mTOR-based immunosuppression in polyomavirus-associated nephropathy","volume":"22","author":"M\u00fchlbacher","year":"2020","journal-title":"Transpl. Infect. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0480","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1097\/TXD.0000000000000641","article-title":"Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin","volume":"3","author":"Kable","year":"2017","journal-title":"Transplant. Direct"},{"issue":"4","key":"10.1016\/j.intimp.2024.112793_b0485","doi-asserted-by":"crossref","first-page":"e13300","DOI":"10.1111\/tid.13300","article-title":"Effects of intravenous immunoglobulin therapy and Fc gamma receptor polymorphisms on BK virus nephropathy in kidney transplant recipients","volume":"22","author":"Moon","year":"2020","journal-title":"Transpl. Infect. Dis."},{"issue":"16","key":"10.1016\/j.intimp.2024.112793_b0490","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/TCRM.S273388","article-title":"Clinical efficacy of intravenous immunoglobulin for BK polyomavirus-associated nephropathy after living kidney transplantation","volume":"8","author":"Matsumura","year":"2020","journal-title":"Ther. Clin. Risk Manag."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T12:34:17Z","timestamp":1731069257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924013146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":98,"alternative-id":["S1567576924013146"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112793","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and opportunities in research on BK virus infection after renal transplantation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112793"}}